| benzodiazepine anxiolytic |
98 |
12.0% |
279 |
8.8% |
0.006 |
| diazepam |
46 |
5.6% |
171 |
5.4% |
0.809 |
| ultrashort-acting benzodiazepine hypnotic |
24 |
2.9% |
55 |
1.7% |
0.029 |
| short-acting benzodiazepine hypnotic |
173 |
21.2% |
460 |
14.6% |
<0.001 |
| middle- to long-acting benzodiazepine hypnotic |
57 |
7.0% |
159 |
5.0% |
0.029 |
| ultrashort-acting non-benzodiazepine hypnotic |
194 |
23.7% |
461 |
14.6% |
<0.001 |
| melatonin-receptor agonist |
34 |
4.2% |
83 |
2.6% |
0.021 |
| hydroxyzine |
119 |
14.6% |
288 |
9.1% |
<0.001 |
| phenothiazine antipsychotic |
25 |
3.1% |
58 |
1.8% |
0.029 |
| haloperidol |
124 |
15.2% |
314 |
9.9% |
<0.001 |
| sulpiride |
26 |
3.2% |
54 |
1.7% |
0.008 |
| risperidone and perospirone |
144 |
17.6% |
343 |
10.9% |
<0.001 |
| multi-acting-receptor-targeted antipsychotics used as hypnotic |
77 |
9.4% |
217 |
6.9% |
0.013 |
| antidepressant used as hypnotic |
50 |
6.1% |
103 |
3.3% |
<0.001 |
| Japanese kampo herbal medicine used as hypnotic and in treatment of BPSD |
50 |
6.1% |
192 |
6.1% |
0.966 |
| other neurological drugs used as hypnotic |
31 |
3.8% |
91 |
2.9% |
0.178 |
| Number of drugs |
|
|
|
|
|
| 0 |
271 |
33.2% |
1519 |
48.1% |
<0.001 |
| 1 |
201 |
24.6% |
746 |
23.6% |
|
| 2 |
147 |
18.0% |
433 |
13.7% |
|
| ≥3 |
198 |
24.2% |
460 |
14.6% |
|
